Key result
Pharmacists' involvement in quality-improvement initiatives presents multiple opportunities to significantly improve adherence to quality measures for patients with coronary artery disease.
Answers are grounded in this paper and cite their sources.
Pharmacists should be actively involved in quality-improvement initiatives to enhance adherence to evidence-based care measures for coronary artery disease.
In this issue of AJHP, Sandhoff and colleagues1 describe a collaborative effort among pharmacists, physicians, and other health care staff to improve the quality of care for patients with coronary artery disease. The need to improve the quality of care was made startlingly clear earlier this year when Asch et al.2 reported that most patients in the United States receive only about half of the recommended health care services. To help address this need, health care has increasingly relied on quality measures. The Centers for Medicare and Medicaid Services (CMS) follows guideline adherence and encourages reporting on eight measures for acute myocardial infarction, four measures for congestive heart failure, six measures for pneumonia, and two measures for surgical prophylaxis.3 All of these measures target interventions or therapies that are associated with improved outcomes, and more than half directly relate to medication use. Pharmacists’ unique involvement in all aspects of the medication-use process presents multiple opportunities to significantly improve adherence to quality measures. Because pharmacists are often overlooked as members of the quality improvement team, pharmacy directors and managers need to advocate for pharmacists’ involvement in quality-improvement initiatives. Involvement in these initiatives may differ by setting; review and reconciliation provide opportunities to detect errors of omission. The value of interventions should not be underestimated—an immunization could save a life.
No takes yet. Share an insight, caveat, or question.
Cynthia LaCivita (2006) conducted an editorial in Coronary artery disease. Pharmacist involvement in quality-improvement initiatives was evaluated. Pharmacists' involvement in quality-improvement initiatives presents multiple opportunities to significantly improve adherence to quality measures for patients with coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: